NASDAQ: CSCI
Cosciens Biopharma Inc Stock Ownership - Who owns Cosciens Biopharma?

Insider buying vs selling

Have Cosciens Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CSCI insiders and whales buy or sell their stock.

CSCI Shareholders

What type of owners hold Cosciens Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
National Bank Of Canada0.19%5,920$16.75kInstitution
Royal Bank Of Canada0.13%3,936$11.13kInstitution
Federation Des Caisses Desjardins Du Quebec0.12%3,873$10.96kInstitution
Td Waterhouse Canada Inc0.12%3,717$10.52kInstitution
Mai Capital Management0.04%1,151$3.26kInstitution
Citigroup Inc0.03%902$2.55kInstitution
Ubs Group Ag0.02%686$1.94kInstitution
Morgan Stanley0.01%400$1.13kInstitution
Sbi Securities Co Ltd0.01%165$466.79Institution
Bnp Paribas Financial Markets0.00%100$282.90Institution

1 of 2

CSCI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CSCI0.67%0.00%
IMRN0.00%0.00%
SNSE9.31%71.61%Net SellingNet Selling
ATHA45.95%31.83%Net Buying
BTAI4.15%95.85%Net Selling

Cosciens Biopharma Stock Ownership FAQ

Who owns Cosciens Biopharma?

Cosciens Biopharma (NASDAQ: CSCI) is owned by 0.67% institutional shareholders, 0.00% Cosciens Biopharma insiders, and 99.33% retail investors. National Bank Of Canada is the largest individual Cosciens Biopharma shareholder, owning 5920.00 shares representing 0.19% of the company. National Bank Of Canada's Cosciens Biopharma shares are currently valued at $18.06k.

If you're new to stock investing, here's how to buy Cosciens Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.